The DOI matches its Crossref record; 126 of the 126 references it cites were found in a registry or an index.
O-GlcNAcylation: A New Cancer Hallmark?
Open accessAbstract
O-linked N-acetylglucosaminylation (O-GlcNAcylation) is a reversible post-translational modification consisting in the addition of a sugar moiety to serine/threonine residues of cytosolic or nuclear proteins. Catalyzed by O-GlcNAc-transferase (OGT) and removed by O-GlcNAcase, this dynamic modification is dependent on environmental glucose concentration. O-GlcNAcylation regulates the activities of a wide panel of proteins involved in almost all aspects of cell biology. As a nutrient sensor, O-GlcNAcylation can relay the effects of excessive nutritional intake, an important cancer risk factor, on protein activities and cellular functions. Indeed, O-GlcNAcylation has been shown to play a significant role in cancer development through different mechanisms. O-GlcNAcylation and OGT levels are increased in different cancers (breast, prostate, colon…) and vary during cell cycle progression. Modulating their expression or activity can alter cancer cell proliferation and/or invasion. Interestingly, major oncogenic factors have been shown to be directly O-GlcNAcylated (p53, MYC, NFκB, β-catenin…). Furthermore, chromatin dynamics is modulated by O-GlcNAc. DNA methylation enzymes of the Tet family, involved epigenetic alterations associated with cancer, were recently found to interact with and target OGT to multi-molecular chromatin-remodeling complexes. Consistently, histones are subjected to O-GlcNAc modifications which regulate their function. Increasing number of evidences point out the central involvement of O-GlcNAcylation in tumorigenesis, justifying the attention received as a potential new approach for cancer treatment. However, comprehension of the underlying mechanism remains at its beginnings. Future challenge will be to address directly the role of O-GlcNAc-modified residues in oncogenic-related proteins to eventually propose novel strategies to alter cancer development and/or progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
GlcNAcylation of a histone methyltransferase in retinoic-acid-induced granulopoiesis
Fujiki, R., Chikanishi, T., Hashiba, W., Ito, H., Takada, I., Roeder, R. G., Kitagawa, H., & Kato, S. (2009) · Nature · doi:10.1038/nature07954 · Cited by 168
RetractedYaşlı Kadınlarda Üreme Sağlığı
Kokanalı, D., & Engin Üstün, Y. (n.d.) · DergiPark (Istanbul University) · Cited by 170,090
Two new Later Stone Age sites from the Final Pleistocene in the Falémé Valley, eastern Senegal
Ndiaye, M., Lespez, L., Tribolo, C., Rassé, M., Hadjas, I., Davidoux, S., Huysecom, É., & Douze, K. (2024) · Monash University Research Portal (Monash University) · doi:10.3929/ethz-b-000667478 · Cited by 23,868
Colman (2022) · doi:10.1073/pnas · Cited by 4,370
Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms
Calle, E. E., & Kaaks, R. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1408 · Cited by 3,613
Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine
Ito, S., Shen, L., Dai, Q., Wu, S. C., Collins, L. B., Swenberg, J. A., He, C., & Zhang, Y. (2011) · Science · doi:10.1126/science.1210597 · Cited by 3,451
A decade of exploring the cancer epigenome—biological and translational implications
Baylin, S. B., & Jones, P. A. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3130 · Cited by 2,871
The complex language of chromatin regulation during transcription
Berger, S. L. (2007) · Nature · doi:10.1038/nature05915 · Cited by 2,768
Systematic review and meta-analysis
(2019) · Providing Information for Health · doi:10.1201/9781315377315-19 · Cited by 2,659
Targeting PI3K signalling in cancer: opportunities, challenges and limitations
Engelman, J. A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2664 · Cited by 2,445
IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer
Greten, F. R., Eckmann, L., Greten, T. F., Park, J. M., Li, Z.-W., Egan, L. J., Kagnoff, M. F., & Karin, M. (2004) · Cell · doi:10.1016/j.cell.2004.07.013 · Cited by 2,433
Caloric Restriction Delays Disease Onset and Mortality in Rhesus Monkeys
Colman, R. J., Anderson, R. M., Johnson, S. C., Kastman, E. K., Kosmatka, K. J., Beasley, T. M., Allison, D. B., Cruzen, C., Simmons, H. A., Kemnitz, J. W., et al. (2009) · Science · doi:10.1126/science.1173635 · Cited by 2,277
Transcriptional Regulation and Its Misregulation in Disease
Lee, T. I., & Young, R. A. (2013) · Cell · doi:10.1016/j.cell.2013.02.014 · Cited by 1,620
Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting
Gialeli, C., Theocharis, A. D., & Karamanos, N. K. (2011) · The FEBS Journal · doi:10.1111/j.1742-4658.2010.07919.x · Cited by 1,607
Reflecting on 25 years with MYC
Meyer, N., & Penn, L. Z. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2231 · Cited by 1,575 · cited 1×
“MYC is a preponderant oncogenic transcriptional factor driving forward cell cycle and replication (90).”
BackgroundCytoplasmic control of nuclear behavior during meiotic maturation of frog oocytes
Masui, Y., & Markert, C. L. (1971) · Journal of Experimental Zoology · doi:10.1002/jez.1401770202 · Cited by 1,545
Cycling of O-linked β-N-acetylglucosamine on nucleocytoplasmic proteins
Hart, G. W., Housley, M. P., & Slawson, C. (2007) · Nature · doi:10.1038/nature05815 · Cited by 1,418
Hart, G. W., Slawson, C., Ramirez-Correa, G., & Lagerlof, O. (2011) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060608-102511 · Cited by 1,317
Brick by brick: metabolism and tumor cell growth
DeBerardinis, R. J., Sayed, N., Ditsworth, D., & Thompson, C. B. (2008) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2008.02.003 · Cited by 1,018
The diverse and complex roles of NF-κB subunits in cancer
Perkins, N. D. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3204 · Cited by 852
Mutant p53 Gain-of-Function in Cancer
Oren, M., & Rotter, V. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a001107 · Cited by 753
Phosphofructokinase 1 Glycosylation Regulates Cell Growth and Metabolism
Yi, W., Clark, P. M., Mason, D. E., Keenan, M. C., Hill, C., Goddard, W. A., Peters, E. C., Driggers, E. M., & Hsieh-Wilson, L. C. (2012) · Science · doi:10.1126/science.1222278 · Cited by 676
Mitotic Phosphorylation of Histone H3: Spatio-Temporal Regulation by Mammalian Aurora Kinases
Crosio, C., Fimia, G. M., Loury, R., Kimura, M., Okano, Y., Zhou, H., Sen, S., Allis, C. D., & Sassone-Corsi, P. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.3.874-885.2002 · Cited by 666
p53 regulates glucose metabolism through an IKK-NF-κB pathway and inhibits cell transformation
Kawauchi, K., Araki, K., Tobiume, K., & Tanaka, N. (2008) · Nature Cell Biology · doi:10.1038/ncb1724 · Cited by 637
Phosphoinositide signalling links O-GlcNAc transferase to insulin resistance
Yang, X., Ongusaha, P. P., Miles, P. D., Havstad, J. C., Zhang, F., So, W. V., Kudlow, J. E., Michell, R. H., Olefsky, J. M., Field, S. J., et al. (2008) · Nature · doi:10.1038/nature06668 · Cited by 617
Biological Mechanisms Linking Obesity and Cancer Risk: New Perspectives
Roberts, D. L., Dive, C., & Renehan, A. G. (2010) · Annual Review of Medicine · doi:10.1146/annurev.med.080708.082713 · Cited by 610
Calorie Restriction, Aging, and Cancer Prevention: Mechanisms of Action and Applicability to Humans
Hursting, S. D., Lavigne, J. A., Berrigan, D., Perkins, S. N., & Barrett, J. C. (2003) · Annual Review of Medicine · doi:10.1146/annurev.med.54.101601.152156 · Cited by 556
NF-κB blockade and oncogenic Ras trigger invasive human epidermal neoplasia
Dajee, M., Lazarov, M., Zhang, J. Y., Cai, T., Green, C. L., Russell, A. J., Marinkovich, M. P., Tao, S., Lin, Q., Kubo, Y., et al. (2003) · Nature · doi:10.1038/nature01283 · Cited by 535
p53 post-translational modification: deregulated in tumorigenesis
Dai, C., & Gu, W. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.09.002 · Cited by 523
Requirement for NF-κB signalling in a mouse model of lung adenocarcinoma
Meylan, E., Dooley, A. L., Feldser, D. M., Shen, L., Turk, E., Ouyang, C., & Jacks, T. (2009) · Nature · doi:10.1038/nature08462 · Cited by 517
TET2 promotes histone O-GlcNAcylation during gene transcription
Chen, Q., Chen, Y., Bian, C., Fujiki, R., & Yu, X. (2013) · Nature · doi:10.1038/nature11742 · Cited by 511
Modification of p53 with O-linked N-acetylglucosamine regulates p53 activity and stability
Yang, W. H., Kim, J. E., Nam, H. W., Ju, J. W., Kim, H. S., Kim, Y. S., & Cho, J. W. (2006) · Nature Cell Biology · doi:10.1038/ncb1470 · Cited by 486
TET2 and TET3 regulate GlcNAcylation and H3K4 methylation through OGT and SET1/COMPASS
Deplus, R., Delatte, B., Schwinn, M. K., Defrance, M., Méndez, J., Murphy, N., Dawson, M. A., Volkmar, M., Putmans, P., Calonne, E., et al. (2013) · The EMBO Journal · doi:10.1038/emboj.2012.357 · Cited by 486
Phosphorylation by Glycogen Synthase Kinase-3 Controls c-Myc Proteolysis and Subnuclear Localization
Gregory, M. A., Qi, Y., & Hann, S. R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m310722200 · Cited by 475
Tumours with PI3K activation are resistant to dietary restriction
Kalaany, N. Y., & Sabatini, D. M. (2009) · Nature · doi:10.1038/nature07782 · Cited by 468
Cooks, T., Pateras, I. S., Tarcic, O., Solomon, H., Schetter, A. J., Wilder, S., Lozano, G., Pikarsky, E., Forshew, T., Rozenfeld, N., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.03.022 · Cited by 466
O-GlcNAc signalling: implications for cancer cell biology
Slawson, C., & Hart, G. W. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3114 · Cited by 458
Chou, T.-Y., Hart, G. W., & Dang, C. V. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.32.18961 · Cited by 453
The nuclear factor kappa B signaling pathway: integrating metabolism with inflammation
Tornatore, L., Thotakura, A. K., Bennett, J., Moretti, M., & Franzoso, G. (2012) · Trends in Cell Biology · doi:10.1016/j.tcb.2012.08.001 · Cited by 447
linking metabolism to epigenetics through O-GlcNAcylation
Hanover, J. A., Krause, M. W., & Love, D. C. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3334 · Cited by 414
FOXM1: From cancer initiation to progression and treatment
Koo, C.-Y., Muir, K. W., & Lam, E. W.-F. (2012) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2011.09.004 · Cited by 406
COP9 signalosome-specific phosphorylation targets p53 to degradation by the ubiquitin system
Bech-Otschir, D. (2001) · The EMBO Journal · doi:10.1093/emboj/20.7.1630 · Cited by 397
Caldwell, S. A., Jackson, S. R., Shahriari, K. S., Lynch, T. P., Sethi, G., Walker, S., Vosseller, K., & Reginato, M. J. (2010) · Oncogene · doi:10.1038/onc.2010.41 · Cited by 396
NF-κB controls energy homeostasis and metabolic adaptation by upregulating mitochondrial respiration
Mauro, C., Leow, S. C., Anso, E., Rocha, S., Thotakura, A. K., Tornatore, L., Moretti, M., De Smaele, E., Beg, A. A., Tergaonkar, V., et al. (2011) · Nature Cell Biology · doi:10.1038/ncb2324 · Cited by 394
β- N -acetylglucosamine (O-GlcNAc) is part of the histone code
Sakabe, K., Wang, Z., & Hart, G. W. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1009023107 · Cited by 373
Sebranek, W., ., M., & Mason, S. T. (2011) · Cited by 371
WILLCOX, B. J., WILLCOX, D. C., TODORIKI, H., FUJIYOSHI, A., YANO, K., HE, Q., CURB, J. D., & SUZUKI, M. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1396.037 · Cited by 370
Garofalo, C., Koda, M., Cascio, S., Sulkowska, M., Kanczuga-Koda, L., Golaszewska, J., Russo, A., Sulkowski, S., & Surmacz, E. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1913 · Cited by 370
Shaping Genetic Alterations in Human Cancer: The p53 Mutation Paradigm
Soussi, T., & Wiman, K. G. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.10.001 · Cited by 368
Aurora‐B phosphorylates Histone H3 at serine28 with regard to the mitotic chromosome condensation
Goto, H., Yasui, Y., Nigg, E. A., & Inagaki, M. (2002) · Genes to Cells · doi:10.1046/j.1356-9597.2001.00498.x · Cited by 349
O-GlcNAc signaling: a metabolic link between diabetes and cancer?
Slawson, C., Copeland, R. J., & Hart, G. W. (2010) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2010.04.005 · Cited by 346
GlcNAcylation of histone H2B facilitates its monoubiquitination
Fujiki, R., Hashiba, W., Sekine, H., Yokoyama, A., Chikanishi, T., Ito, S., Imai, Y., Kim, J., He, H. H., Igarashi, K., et al. (2011) · Nature · doi:10.1038/nature10656 · Cited by 330
Vella, P., Scelfo, A., Jammula, S., Chiacchiera, F., Williams, K., Cuomo, A., Roberto, A., Christensen, J., Bonaldi, T., Helin, K., et al. (2013) · Molecular Cell · doi:10.1016/j.molcel.2012.12.019 · Cited by 326
Willcox, D. C., Willcox, B. J., Todoriki, H., & Suzuki, M. (2009) · Journal of the American College of Nutrition · doi:10.1080/07315724.2009.10718117 · Cited by 311
Itkonen, H. M., Minner, S., Guldvik, I. J., Sandmann, M. J., Tsourlakis, M. C., Berge, V., Svindland, A., Schlomm, T., & Mills, I. G. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0549 · Cited by 292
Slawson, C., Zachara, N. E., Vosseller, K., Cheung, W. D., Lane, M. D., & Hart, G. W. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503396200 · Cited by 291
Lynch, T. P., Ferrer, C. M., Jackson, S. R., Shahriari, K. S., Vosseller, K., & Reginato, M. J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.302547 · Cited by 286
Glycan-dependent signaling: O-linked N-acetylglucosamine
HANOVER, J. A. (2001) · The FASEB Journal · doi:10.1096/fj.01-0094rev · Cited by 283
NFκB activation is associated with its O -GlcNAcylation state under hyperglycemic conditions
Yang, W. H., Park, S. Y., Nam, H. W., Kim, D. H., Kang, J. G., Kang, E. S., Kim, Y. S., Lee, H. C., Kim, K. S., & Cho, J. W. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806198105 · Cited by 263
O-GlcNAcylation is a novel regulator of lung and colon cancer malignancy
Mi, W., Gu, Y., Han, C., Liu, H., Fan, Q., Zhang, X., Cong, Q., & Yu, W. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.01.009 · Cited by 259
Ma, Z., Vocadlo, D. J., & Vosseller, K. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.470047 · Cited by 253
Chromatin-associated Protein Phosphatase 1 Regulates Aurora-B and Histone H3 Phosphorylation
Murnion, M. E., Adams, R. R., Callister, D. M., Allis, C. D., Earnshaw, W. C., & Swedlow, J. R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102288200 · Cited by 250
Modulation of transcription factor function by O-GlcNAc modification
Özcan, S., Andrali, S. S., & Cantrell, J. E. L. (2010) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2010.02.005 · Cited by 249
O‐GlcNAcase is essential for embryonic development and maintenance of genomic stability
Yang, Y. R., Song, M., Lee, H., Jeon, Y., Choi, E., Jang, H., Moon, H. Y., Byun, H., Kim, E., Kim, D. H., et al. (2012) · Aging Cell · doi:10.1111/j.1474-9726.2012.00801.x · Cited by 244
Zhang, Z.-J., Zheng, Z.-J., Shi, R., Su, Q., Jiang, Q., & Kip, K. E. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1267 · Cited by 241
Leptin signaling in breast cancer: An overview
Cirillo, D., Rachiglio, A. M., la Montagna, R., Giordano, A., & Normanno, N. (2008) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21911 · Cited by 235
Cheung, W. D., & Hart, G. W. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801222200 · Cited by 233
Lymphocyte activation induces rapid changes in nuclear and cytoplasmic glycoproteins.
Kearse, K. P., & Hart, G. W. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.5.1701 · Cited by 229
Glycosylation of the c-Myc transactivation domain.
Chou, T. Y., Dang, C. V., & Hart, G. W. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.10.4417 · Cited by 225
Cracking the O-GlcNAc code in metabolism
Ruan, H.-B., Singh, J. P., Li, M.-D., Wu, J., & Yang, X. (2013) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2013.02.002 · Cited by 225
GlcNAcylation Plays an Essential Role in Breast Cancer Metastasis
Gu, Y., Mi, W., Ge, Y., Liu, H., Fan, Q., Han, C., Yang, J., Han, F., Lu, X., & Yu, W. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-1887 · Cited by 215
Snail1 is stabilized by O‐GlcNAc modification in hyperglycaemic condition
Park, S. Y., Kim, H. S., Kim, N. H., Ji, S., Cha, S. Y., Kang, J. G., Ota, I., Shimada, K., Konishi, N., Nam, H. W., et al. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.254 · Cited by 202
Loss of p53 enhances catalytic activity of IKKβ through O-linked β-N-acetyl glucosamine modification
Kawauchi, K., Araki, K., Tobiume, K., & Tanaka, N. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813210106 · Cited by 193
Masui, Y. (2001) · Differentiation · doi:10.1046/j.1432-0436.2001.690101.x · Cited by 189
Regulation of the O-Linked β-N-Acetylglucosamine Transferase by Insulin Signaling
Whelan, S. A., Lane, M. D., & Hart, G. W. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800677200 · Cited by 186
Slawson, C., Lakshmanan, T., Knapp, S., & Hart, G. W. (2008) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-11-1146 · Cited by 177
Metabolic syndrome and risk of subsequent colorectal cancer
Pais, R., Silaghi, H., Silaghi, A. C., Rusu, M. L., & Dumitrascu, D. L. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.5141 · Cited by 174
O-GlcNAc modification, insulin signaling and diabetic complications
Issad, T., Masson, E., & Pagesy, P. (2010) · Diabetes & Metabolism · doi:10.1016/j.diabet.2010.09.001 · Cited by 170
Self-citationMetabolic surgery and cancer: Protective effects of bariatric procedures
Ashrafian, H., Ahmed, K., Rowland, S. P., Patel, V., Gooderham, N. J., Holmes, E. C., Darzi, A. W., & Athanasiou, T. (2010) · Cancer · doi:10.1002/cncr.25738 · Cited by 168
Zhu, Q., Zhou, L., Yang, Z., Lai, M., Xie, H., Wu, L., Xing, C., Zhang, F., & Zheng, S. (2012) · Medical Oncology · doi:10.1007/s12032-011-9912-1 · Cited by 168
Zhang, S., Roche, K. C., Nasheuer, H., & Lowndes, N. F. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.284885 · Cited by 161
Molecular & Cellular Proteomics
(2021) · Molecular & Cellular Proteomics · doi:10.1074/mcp · Cited by 158
O-GlcNAc modification of transcription factors, glucose sensing and glucotoxicity
Issad, T., & Kuo, M.-S. (2008) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2008.09.001 · Cited by 149
Self-citationO-GlcNAc Transferase Regulates Mitotic Chromatin Dynamics
Sakabe, K., & Hart, G. W. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.158170 · Cited by 149
Aberrant O-GlcNAcylation characterizes chronic lymphocytic leukemia
Shi, Y., Tomic, J., Wen, F., Shaha, S., Bahlo, A., Harrison, R., Dennis, J. W., Williams, R., Gross, B. J., Walker, S., et al. (2010) · Leukemia · doi:10.1038/leu.2010.152 · Cited by 147
Parallel Identification of O-GlcNAc-Modified Proteins from Cell Lysates
Tai, H., Khidekel, N., Ficarro, S. B., Peters, E. C., & Hsieh‐Wilson, L. C. (2004) · Journal of the American Chemical Society · doi:10.1021/ja047872b · Cited by 131
Lefebvre, T., Dehennaut, V., Guinez, C., Stichelen, S. O.-V., Drougat, L., Mir, A., Mortuaire, M., Vercoutter‐Edouart, A., & Michalski, J. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.08.008 · Cited by 127
Self-citationFong, J. J., Nguyen, B. L., Bridger, R., Medrano, E. E., Wells, L., Pan, S., & Sifers, R. N. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.315804 · Cited by 126
Kalo, E., Kogan-Sakin, I., Solomon, H., Natan, E. B., Shay, M., Shetzer, Y., Dekel, E., Goldfinger, N., Buganim, Y., Stambolsky, P., et al. (2012) · Journal of Cell Science · doi:10.1242/jcs.106815 · Cited by 116
Kuo, M.-S., Zilberfarb, V., Gangneux, N., Christeff, N., & Issad, T. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.02.010 · Cited by 112
Self-citationGene expression of O-GlcNAc cycling enzymes in human breast cancers
Krześlak, A., Forma, E., Bernaciak, M., Romanowicz, H., & Bryś, M. (2011) · Clinical and Experimental Medicine · doi:10.1007/s10238-011-0138-5 · Cited by 110
Health in children: A conceptual framework for use in healthy ageing research
Felix, J. F., Voortman, T., van den Hooven, E. H., Sajjad, A., Leermakers, E. T. M., Tharner, A., Jong, J. C. K., Duijts, L., Verhulst, F. C., de Jongste, J. C., et al. (2013) · Maturitas · doi:10.1016/j.maturitas.2013.09.011 · Cited by 107
Champattanachai, V., Netsirisawan, P., Chaiyawat, P., Phueaouan, T., Charoenwattanasatien, R., Chokchaichamnankit, D., Punyarit, P., Srisomsap, C., & Svasti, J. (2013) · PROTEOMICS · doi:10.1002/pmic.201200126 · Cited by 103
Doğan, S., Hu, X., Zhang, Y., Maihle, N. J., Grande, J. P., & Cleary, M. P. (2007) · Breast Cancer Research · doi:10.1186/bcr1840 · Cited by 103
Hurvitz, S. A., & Pietras, R. J. (2008) · Cancer · doi:10.1002/cncr.23875 · Cited by 100
Nutrition, metabolic factors and cancer risk
Dossus, L., & Kaaks, R. (2008) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2008.08.003 · Cited by 93
Stichelen, S. O.-V., Guinez, C., Mir, A., Pérez-Cervera, Y., Liu, C., Michalski, J., & Lefebvre, T. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00390.2011 · Cited by 93
Self-citationRambaruth, N. D. S., Greenwell, P., & Dwek, M. V. (2012) · Glycobiology · doi:10.1093/glycob/cws051 · Cited by 90
Glucose induces an autocrine activation of the Wnt/β-catenin pathway in macrophage cell lines
Anagnostou, S. H., & Shepherd, P. R. (2008) · Biochemical Journal · doi:10.1042/bj20081426 · Cited by 88
Dehennaut, V., Slomianny, M., Page, A., Vercoutter‐Edouart, A., Jessus, C., Michalski, J., Vilain, J., Bodart, J., & Lefebvre, T. (2008) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m700494-mcp200 · Cited by 88
Self-citationChen, Y., Du, J., Zhou, L., Liu, X.-H., Zhao, Y., Nakanishi, H., & Li, Y. (2006) · Chemistry & Biology · doi:10.1016/j.chembiol.2006.06.017 · Cited by 86
Substrate and product analogues as human O-GlcNAc transferase inhibitors
Dorfmueller, H. C., Borodkin, V. S., Blair, D. E., Pathak, S., Navratilova, I. H., & van Aalten, D. M. F. (2010) · Amino Acids · doi:10.1007/s00726-010-0688-y · Cited by 85
Diabetes mellitus, hyperglycaemia and cancer
Simon, D., & Balkau, B. (2010) · Diabetes & Metabolism · doi:10.1016/j.diabet.2010.04.001 · Cited by 82
Insulin resistance, obesity and breast cancer risk
Pichard, C., Plu‐Bureau, G., Castro, M. N.-E., & Gompel, A. (2008) · Maturitas · doi:10.1016/j.maturitas.2008.03.002 · Cited by 82
Kuo, M.-S., Zilberfarb, V., Gangneux, N., Christeff, N., & Issad, T. (2008) · Biochimie · doi:10.1016/j.biochi.2008.03.005 · Cited by 81
Self-citationDrougat, L., Stichelen, S. O.-V., Mortuaire, M., Foulquier, F., Lacoste, A., Michalski, J., Lefebvre, T., & Vercoutter‐Edouart, A. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.08.024 · Cited by 79
Self-citationO-Linked N-Acetylglucosamine and Cancer: Messages from the Glycosylation of C-Myc
Chou, T., & Hart, G. W. (2001) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-1267-7_26 · Cited by 74
Pierre‐Eugène, C., Pagésy, P., Nguyen, T. T., Neuillé, M., Tschank, G., Tennagels, N., Hampe, C., & Issad, T. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041992 · Cited by 72
Self-citationSerum-stimulated cell cycle entry promotes ncOGT synthesis required for cyclin D expression
Stichelen, S. O.-V., Drougat, L., Dehennaut, V., Yazidi‐Belkoura, I. E., Guinez, C., Mir, A.-M., Michalski, J., Vercoutter‐Edouart, A., & Lefebvre, T. (2012) · Oncogenesis · doi:10.1038/oncsis.2012.36 · Cited by 69
Self-citationKanwal, S., Fardini, Y., Pagésy, P., N’Tumba-Byn, T., Pierre‐Eugène, C., Masson, E., Hampe, C., & Issad, T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069150 · Cited by 69
Self-citationSlawson, C. M., Pidala, J., & Potter, R. L. (2001) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(01)00067-9 · Cited by 69
Energy availability and mammary carcinogenesis: effects of calorie restriction and exercise
Gillette, C. D. (1997) · Carcinogenesis · doi:10.1093/carcin/18.6.1183 · Cited by 57
Kwei, K. A., Baker, J. B., & Pelham, R. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046518 · Cited by 56
Jin, F.-Z., Yu, C., Zhao, D., Wu, M., & Yang, Z. (2013) · Experimental Cell Research · doi:10.1016/j.yexcr.2013.03.013 · Cited by 56
O-GlcNAcylation is involved in the transcriptional activity of EWS-FLI1 in Ewing's sarcoma
Bachmaier, R., Aryee, D. N. T., Jug, G., Kauer, M. O., Kreppel, M., Lee, K. A. W., & Kovar, H. (2009) · Oncogene · doi:10.1038/onc.2008.484 · Cited by 53
Microinjection of recombinant O-GlcNAc transferase potentiates Xenopus oocytes M-phase entry
Dehennaut, V., Hanoulle, X., Bodart, J., Vilain, J., Michalski, J., Landrieu, I., Lippens, G. M., & Lefebvre, T. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.02.063 · Cited by 52
Self-citationHaltiwanger, R. S., & Philipsberg, G. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.13.8752 · Cited by 51
Fang, B., & Miller, M. W. (2001) · Experimental Cell Research · doi:10.1006/excr.2000.5110 · Cited by 46
Copeland, R. J., Han, G., & Hart, G. W. (2013) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201300001 · Cited by 46
Slawson, C. M., Shafii, S. M., Amburgey, J. E., & Potter, R. L. (2002) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(02)00369-0 · Cited by 45
Elevation of nucleocytoplasmic β-N-acetylglucosaminidase (O-GlcNAcase) activity in thyroid cancers
Krześlak, A. (2010) · International Journal of Molecular Medicine · doi:10.3892/ijmm_00000387 · Cited by 39
Guo, K., Gan, L., ZHANG, S., Cui, F. J., Wang, C., Li, Y., KANG, N. X., GAO, M. D., & Liu, K. Y. (2012) · Oncology Reports · doi:10.3892/or.2012.1844 · Cited by 38
The tumor suppressor HIC1 (hypermethylated in cancer 1) is O ‐GlcNAc glycosylated
Lefebvre, T., Pinte, S., Guérardel, C., Deltour, S., Martin, N., Slomianny, M., Michalski, J., & Leprince, D. (2004) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.2004.04316.x · Cited by 35
Self-citationSurvey of O-GlcNAc level variations in Xenopus laevis from oogenesis to early development
Dehennaut, V., Lefebvre, T., Leroy, Y., Vilain, J., Michalski, J., & Bodart, J. (2008) · Glycoconjugate Journal · doi:10.1007/s10719-008-9166-0 · Cited by 26
Self-citationSchlummer, S., Vetter, R., Kuder, N., Henkel, A. W., Chen, Y., Li, Y., Kuhlmann, J., & Waldmann, H. (2005) · ChemBioChem · doi:10.1002/cbic.200500212 · Cited by 17
A sweet TET‐à‐tête‐synergy of TET proteins and O‐GlcNAc transferase in transcription
Mariappa, D., Pathak, S., & van Aalten, D. M. F. (2013) · The EMBO Journal · doi:10.1038/emboj.2013.26 · Cited by 15
Cited by
Hallmarks of glycosylation in cancer
Munkley, J., & Elliott, D. J. (2016) · Oncotarget · doi:10.18632/oncotarget.8155 · Cited by 521
Nutrient regulation of signaling and transcription
Hart, G. W. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.aw119.003226 · Cited by 345
Regulation of the Hippo-YAP Pathway by Glucose Sensor O-GlcNAcylation
Peng, C., Zhu, Y., Zhang, W., Liao, Q., Chen, Y., Zhao, X., Guo, Q., Shen, P., Zhen, B., Qian, X., et al. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.10.010 · Cited by 280
O-GlcNAc profiling: from proteins to proteomes
Ma, J., & Hart, G. W. (2014) · Clinical Proteomics · doi:10.1186/1559-0275-11-8 · Cited by 276
Epigenetics in Turner syndrome
Álvarez-Nava, F., & Lanes, R. (2018) · Clinical Epigenetics · doi:10.1186/s13148-018-0477-0 · Cited by 79
Metadata
- Authors
- Fardini, Y., Dehennaut, V., Lefebvre, T., & Issad, T.
- Venue
- Frontiers in Endocrinology
- Publisher
- Frontiers Media SA
- Published
- 2013
- Volume
- 4
- Pages
- 99-99
- ISSN
- 1664-2392 (ISSN-L)
- OpenAlex
- W2154677603
- Cited by
- 263
- References
- 126
- FWCI
- 8.20
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.